Share of U.S. adults who felt MMR vaccine benefits outweigh risks 2016, by age

Percentage of adults in the U.S. who thought the benefits of the measles, mumps and rubella vaccine outweighed the risks as of 2016, by age

CharacteristicBenefits outweigh the risksRisks outweigh the benefits
18 to 29 years 79% 18%
30 to 49 years 91% 9%
50 to 64 years 91% 6%
65 years and older 90% 6%
Total 88% 10%
Created with Highcharts 7.2.2Percentage of respondents79%79%91%91%91%91%90%90%88%88%18%18%9%9%6%6%6%6%10%10%Benefits outweigh the risksRisks outweigh the benefits18 to 29 years30 to 49 years50 to 64 years65 years and olderTotal
0%20%40%60%80%100%120%
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2017

Region

United States

Survey time period

May 10 to June 6, 2016

Number of respondents

1,549 respondents

Age group

18 years and older

Method of interview

Online panel

Supplementary notes

MMR- Measles, mumps, rubella.
Note: Respondents who did not give an answer are not shown.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Statistics on " Vaccinations in Italy "

Other statistics that may interest you Vaccinations in Italy

Immunization coverage among children and adolescents

7

Immunization coverage trends among two-year-olds

8

Immunization coverage among two-year-olds by region

8

HPV vaccination

5

Flu vaccination

5

COVID-19 vaccine

5

Further related statistics

10
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.